Related Experiment Video

Updated: Apr 5, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression

Merav Kedmi1, Aldema Sas-Chen2, Yosef Yarden3

  • 1Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. meravk@tlvmc.gov.il.

Journal of Clinical Medicine
|August 20, 2015
PubMed

Insights

Cancer progression involves cell growth and spread, regulated by growth factors and microRNAs. Targeting their complex interactions, like the epidermal growth factor pathway, offers new therapeutic strategies for cancer treatment and drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Tumor progression relies on cell proliferation, migration, invasion, and angiogenesis, processes governed by growth factors and intracellular signaling pathways.
  • Growth factors and microRNAs form intricate regulatory networks crucial for tumor development and progression.
  • Oncogenic mutations frequently hijack growth factor signaling, making these pathways targets for anti-cancer drugs.

Purpose of the Study:

  • To review the interplay between growth factors and microRNAs in cancer progression.
  • To highlight the epidermal growth factor (EGF) pathway as a key example of this crosstalk.
  • To discuss the clinical implications of microRNA-growth factor interactions in cancer therapy and drug resistance.

Main Methods:

  • Literature review focusing on the molecular mechanisms of growth factor and microRNA interactions in cancer.
  • Analysis of signaling pathways, particularly the epidermal growth factor (EGF) pathway.
  • Examination of clinical studies related to microRNA-targeted cancer therapies and drug resistance.

Main Results:

  • Growth factors and microRNAs engage in a complex regulatory network, with recurring modules dominating their interactions.
  • The epidermal growth factor (EGF) pathway exemplifies the critical alliance between growth factors and microRNAs in driving tumor progression.
  • Specific microRNAs modulate the abundance of proteins involved in growth factor signaling, creating feedback loops.

Conclusions:

  • The intricate crosstalk between growth factors and microRNAs is central to cancer cell proliferation, migration, and invasion.
  • Targeting these molecular interactions, especially within the EGF pathway, holds significant promise for developing novel cancer therapies.
  • Understanding this crosstalk is essential for overcoming drug resistance and improving treatment outcomes in oncology.
Keywords:
cancer therapycarcinomaepidermal growth factor (EGF)metastasisnetworkreceptor tyrosine kinasesignal transductiontranscription

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

512

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K